Skip to content

A study to compare two different aramchol formulations in healthy volunteers.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-507445-28-00
Acronym
CGA23001
Enrollment
16
Registered
2024-12-13
Start date
2024-12-18
Completion date
2025-06-12
Last updated
2024-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Primary sclerosing cholangitis

Interventions

None listed

Sponsors

CCDRD Cooperative Clinical Drug Research and Development AG, Galmed Research And Development Ltd.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Bulgaria

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026